By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



27220 Turnberry Lane
Suite 200
Valencia  California  91355  U.S.A.
Phone: 800-718-2056 Fax: n/a

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.

Further information about QIAGEN can be found at

Key Statistics

Ownership: Public

Web Site: QIAGEN Inc.
Employees: 210
Symbol: QGEN

Company News
QIAGEN Inc. (QGEN)'s TB Test Cuts Estimate Of Latent TB Incidence In China 2/11/2015 2:36:30 PM
ArcherDX Launches From QIAGEN Inc. (QGEN) Acquisition Of Enzymatics 1/12/2015 10:40:15 AM
QIAGEN Inc. (QGEN) Announces First-Ever Regulatory Registration Of A Lung Cancer Companion Diagnostic Based On Liquid Biopsies 1/12/2015 7:13:55 AM
QIAGEN Inc. (QGEN) To Distribute Altona Diagnostic's RealStar Ebolavirus RT-PCR Kit 1.0, Recently Authorized By The FDA For Emergency Use 12/5/2014 1:14:34 PM
QIAGEN Inc. (QGEN) Signs Ninth Master Collaboration Agreement For Companion Diagnostics 11/12/2014 7:10:21 AM
QIAGEN Inc. (QGEN) Release: New Study Confirms Superior Sensitivity Of DIGENE HC2 HPV DNA Test Vs. The Other FDA-Approved Tests For HPV 9/30/2014 11:42:43 AM
FDA Clears QIAGEN Inc. (QGEN)'s QIAsymphony RGQ MDx System For C. Difficile 5/5/2014 3:22:36 PM
QIAGEN Inc. (QGEN) To Depart Old Headquarters, Expand Two Other Maryland Campuses 4/16/2014 7:20:26 AM
Maverix Strengthens Strategic Co-Marketing Alliance With QIAGEN Inc. (QGEN) 4/2/2014 11:25:20 AM
QIAGEN Inc. (QGEN) Launches New-Gen TB Test In China 3/21/2014 12:05:24 PM